Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000012

President, Research & Develop. gave up 6,138 shares (to pay taxes)

  • President, Research & Develop. acquired 60,800 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2025-03-01 Grant or award +60,800 205,797 D: show line 1 in the form
Sethuraman Natarajan President, Research & Develop. 2025-03-03 Shares withheld for taxes −6,138 $11.68 $71,683 199,659 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan President, Research & Develop. 2025-03-01 Grant or award · Stock Option (Right to Buy) +90,800 90,800 D: show line 3 in the form
Loading xslF345X05/wk-form4_1741125479.xml…